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decline in elderly women, whereas current BMI may be used as a
marker of prospective dementia in elderly men.P3-557 ASSOCIATIONS OF PITUITARY-OVARIANHORMONES AND BRAIN STRUCTURE IN
RECENTLYMENOPAUSALWOMENUSING
HORMONE THERAPYJuliana M. Kling1, Virginia M. Miller2, Nirubol Tosakulwong2,
Timothy G. Lesnick2, Kejal Kantarci2, 1Mayo Clinic, Scottsdale,
AZ, USA; 2Mayo Clinic, Rochester, MN, USA. Contact e-mail: kling.
juliana@mayo.edu
Background: Treatment with oral conjugated equine estrogen
(oCEE) or transdermal 17 b-estradiol (tE2) in recently menopausal
women influences the longitudinal increase in white matter hyper-
intensity volumes onMRI. The relationship of changes in pituitary-
ovarian hormone levels during menopausal hormone therapies and
the change in white matter hyperintensities (WMH) is unknown.
Methods: Cognitively healthy women aged 42 - 56 years and within
6-36 months of their last menstrual period enrolled in the KronosEarly Estrogen Prevention Study (KEEPS) were randomized to 4
years of 0.45 mg/d o-CEE daily, 50 mg/d tE2 weekly or placebo
pills and patches. Women in the active treatment groups also
received oral 200 mg/d micronized progesterone for the first 12
d of each month to protect the uterus. Estradiol (E1), estrone
(E2), and follicle stimulating hormone (FSH) were measured by
high sensitive liquid chromatography/mass spectroscopy from
serum samples collected at baseline prior to randomization and
48 months after randomization. MRIs were also performed at base-
line and month 48 (N¼ 78). The longitudinal change in WMH vol-
ume was determined from FLAIR MRIs using a semi-automated
image segmentation algorithm. Results: No statistically significant
associations between FSH, E1 or E2 levels andWMHwere found at
baseline. During the four years of menopausal hormone therapies,
the greater the longitudinal decline in FSH in the tE2 group the
lesser the longitudinal increase in WMH volume. In both the tE2
and oCEE groups, the greater the longitudinal increase in E1, the
lesser the increase in WMH volume. A similar pattern, which did
not reach statistical significance, was observed between increases
in E2 and increases in WMH in the tE2 group (Table 1).
Conclusions: Changes in circulating levels of pituitary-ovarian
hormone during menopausal hormone therapies may partially
explain the changes in WMH volume in recently menopausal
women. Long term follow up in a larger cohort of women
measuring all pituitary-ovarian hormones would further clarify
these relationships.P3-558 EXPOSURES PRIOR TO AGE 16 ARE
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Bradley Petrowiz1, Jessica D. Faul1, Erin B. Ware1, 1University of
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Baltimore, MD, USA. Contact e-mail: bakulski@umich.eduBackground: Alzheimer’s disease (AD) is a prevalent neurodegen-
erative disease with risk attributed to both genetic and environ-
mental factors. The environmental etiology of AD is not well
characterized, and the relevant exposure window of susceptibility
is likely prior to symptom onset. Environment in the early life
period has not yet been comprehensively tested for association
with later life dementia. Methods: In the U.S. nationally represen-
tative Health and Retirement Study (HRS) (n¼16,316; 2010
wave) we examined 23 exposures occurring prior to age 16 via
retrospective questionnaire. We tested for associations between
exposures and dementia status (dementia, cognitively impaired
non-demented, cognitively normal) using proportional odds
models. Results: Depression prior to age 16 was associated with
2.38 (95% confidence interval (CI): 1.66, 3.41) times higher odds
of dementia in later life and 1.91 (95% CI: 1.55, 2.34) times higher
odds of cognitive impairment. Headaches or migraines prior to age
16 was associated with 1.53 (95% CI: 1.16, 2.01) times higher odds
of dementia in later life and 1.63 (95% CI: 1.41, 1.90) times higher
Poster Presentations: Tuesday, July 16, 2019 P1189odds of cognitive impairment. High blood pressure prior to age 16
was associated with 2.76 (95% CI:1.06, 7.19) times higher odds of
dementia in later life and 2.68 (95% CI: 1.54, 4.67) times higher
odds of cognitive impairment, even after adjusting for current blood
pressure. All reported odds ratios are relative to normal cognition.
Conclusions: Exposures occurring in early life or conditions origi-
nating in early life may be important risk factors for later onset
of dementia. Though we exclude participants with cognitive
impairment at time of questionnaire, longitudinal research may
be subject to challenges related to recall of information and differ-
ential survival.P3-559 APATHY IS ASSOCIATEDWITH RISK OFINCIDENT DEMENTIA AMONG
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Meredith.Bock@ucsf.eduBackground: Neuropsychiatric symptoms (NPS) are common in the
clinical phase of dementia. Apathy is the most prevalent NPS in all
dementia subtypes and may be an important prodromal sign associ-
ated with progression to dementia, yet this has not been rigorously
investigated in a population-based sample. Methods: We studied
2023 participants from the Health, Aging, and Body Composition
(Health ABC) study, a prospective cohort study of community-
dwelling white and black older adults. The modified Apathy Eval-
uation Scale (5 self-reported items with total score 0-15) was
administered at year 6, our study baseline. We divided patients
into tertiles based on symptoms of low, moderate, or severe apathy.
Prevalent dementia was excluded and incident dementia was
measured through Year 15, determined by dementia medication
use, hospital records, or significant cognitive decline on global
cognition ( 1.5 SD race-specific decline on the Modified Mini-
Mental State Examination). We used ANOVA and Chi Squared
tests to examine differences in baseline demographics by apathy
severity. We examined the association between baseline apathy
group and incident dementia using a logistic regression model
with low apathy as a reference. We then adjusted the model for
age, gender, race, years of education, and comorbid depression
(measured by the Center for Epidemiologic Studies Depression
Scale).Results: In the cohort, 743 participants (37%) reported mod-
erate symptoms and 509 participants (25%) reported severe symp-
toms of apathy. There were 381(18%) cases of incident dementia
over 9 years of follow-up. At baseline, greater apathy was associ-
ated with non-white race (p<0.001), fewer years of education
(p<0.001), tobacco use (p¼0.005), higher body mass index
(p¼0.01), and depression (p<0.001). Moderate apathy (OR 1.4,
95% CI 1.1-1.9) and severe apathy (OR 1.9, 95% CI 1.5-2.6)
were associated with an increased risk of incident dementia in un-
adjusted models. In adjusted models, severe apathy was associated
with an increased risk of incident dementia (25% vs. 14%, OR 1.5,
95% CI 1.1-2.1). Conclusions: In a diverse cohort of community-
dwelling adults, apathy was associated with increased risk of devel-
oping dementia. A brief assessment of apathy may have clinical
utility in risk stratifying the elderly for progression to dementia.P3-560 THE ROLES OFANXIETYAND FAMILYHISTORY OF DEMENTIA IN
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Background: Older adults with a first-degree family history of Alz-
heimer’s disease report greater subjective cognitive decline
(SCD). Further, it has been suggested that personal experience
with Alzheimer’s disease (AD) can influence one’s perceived
risk of disease and ownmemory changes. Previous research shows
SCD is very closely associated with mood symptoms in older
adults. Little is known about these relationships in middle aged
adults, a group likely to be caring for parents with dementia.
The aim of this study was to investigate the roles of self-reported
anxiety and family history of Dementia in predicting SCD severity
in healthy middle aged adults. Methods: Participants (n¼1384)
aged 40-70 enrolled in the Healthy Brain Project reported
whether they have an immediate family history of dementia.
They also completed the Depression Anxiety and Stress Scale
(DASS) and the Cognitive Function Instrument (CFI; Amariglio
et al., 2015). Regression analyses and a chi square test of inde-
pendence were conducted. Results: There was no relationship
between family history of dementia and the total score of
SCD self-rated on the CFI. However, a chi square revealed an
association between family history and an individual item
related to worry about memory and thinking abilities
(X2¼5.08, p¼.024). A regression analysis, including age and
sex as covariates, indicated a significant relationship between
anxiety and SCD (b¼ 0.961, p <.001). No interaction between
anxiety and family history on SMC was found. Conclusions:
Although middle-aged adults with a family history of dementia
were not more likely to self-report more severe memory defi-
cits, they still acknowledged greater concern, a core component
of the SCD plus criteria (Jessen et al., 2014). As such, these
findings support the notion that objective cognitive decline,
